Works matching AU Kothai, P.


Results: 6
    1
    2
    3
    4
    5
    6

    A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).

    Published in:
    Breast Cancer Research & Treatment, 2024, v. 207, n. 2, p. 275, doi. 10.1007/s10549-024-07417-4
    By:
    • Mezzanotte-Sharpe, Jessica;
    • ONeill, Anne;
    • Mayer, Ingrid A.;
    • Arteaga, Carlos L.;
    • Yang, Ximing J.;
    • Wagner, Lynne I.;
    • Cella, David;
    • Meropol, Neal J.;
    • Alpaugh, R. Katherine;
    • Saphner, Thomas J.;
    • Swaney, Robert E.;
    • Hoelzer, Karen L.;
    • Gradishar, William J.;
    • Abramson, Vandana G.;
    • Sundaram, P. Kothai;
    • Jilani, Shamim Z.;
    • Perez, Edith A.;
    • Lin, Nancy U.;
    • Jahanzeb, Mohammad;
    • Wolff, Antonio C.
    Publication type:
    Article